Corpus Intelligence IC Memo — MEDICAL CENTER OF DELTONA 2026-04-26 12:29 UTC
IC Memo — MEDICAL CENTER OF DELTONA
Investment Committee Memorandum | FL | 43 beds | Grade D | EBITDA uplift $3.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MEDICAL CENTER OF DELTONA

CCN 100330 | VOLUSIA, FL | 43 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

MEDICAL CENTER OF DELTONA is a 43-bed under-performing / distressed in VOLUSIA, FL with $45.4M in net patient revenue and a -30.2% operating margin. The hospital serves a payer mix of 18.6% Medicare, 2.2% Medicaid, and 79.2% commercial.

Thesis: Turnaround. Our ML models identify $3.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -30.2% to -22.8% (+736bps).

Net Revenue HCRIS$45.4M
Current EBITDA COMPUTED$-13.7M
Operating Margin COMPUTED-30.2%
Occupancy HCRIS39.0%
Revenue / Bed COMPUTED$1.1M
Net-to-Gross HCRIS22.5%
Distress Probability ML49.0%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
83
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of -30.2% places it below the state median. Among 83 size-comparable peers (22-86 beds), the median margin is 3.1%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (22-86), prioritizing same-state peers. 83 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MEDICAL CENTER OF DELTONA (Target)FL43$45.4M-30.2%
ASCENSION SACRED HEART EMERALDFL80$187.9M16.1%
VIERA HOSPITAL INCFL84$162.9M16.9%
GULF BREEZE HOSPITALFL65$121.8M12.8%
OVIEDO MEDICAL CENTERFL64$110.9M7.4%
SANTA ROSA MEDICAL CENTERFL86$101.4M17.1%
ST. CLOUD REGIONAL MEDICAL CENFL84$97.1M1.2%
BARTOW REGIONAL MEDICAL CENTERFL72$90.9M11.3%
BAPTIST MEDICAL CTR-NASSAUFL54$85.1M2.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$953K+210bp18mo
Cost to Collect4.5%2.5%$907K+200bp12mo
Denial Rate Reduction12.0%6.5%$898K+198bp12mo
A/R Days Reduction5200.0%3800.0%$552K+122bp9mo
Clean Claim Rate88.0%96.0%$29K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$953K
Cost to Collect
$907K
Denial Rate Reduction
$898K
A/R Days Reduction
$552K
Clean Claim Rate
$29K
Total EBITDA Uplift$3.3M
Current EBITDA$-13.7M
+ RCM Uplift+$3.3M
Pro Forma EBITDA$-10.3M
Current Margin-30.2%
Pro Forma Margin-22.8%
WC Released (1x)$1.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-21.1M$-56.9M0.00x-100.0%
Base (11x exit)10.0x11.0x$-21.1M$-69.4M0.00x-100.0%
Bull Case9.0x11.0x$-19.0M$-65.2M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-19.0M$-76.7M0.00x-100.0%
Bear Case11.0x10.0x$-23.2M$-66.7M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-23.2M$-80.9M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 83 hospitals with 22-86 beds
  • Same-state prioritization (n=84)
  • Comp margins: P25=-15.2% / P50=3.1% / P75=11.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.